Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size : A randomized controlled trialFISCELLA, Kevin; EISINGER, Steven H; MELDRUM, Sean et al.Obstetrics and gynecology (New York. 1953). 2006, Vol 108, Num 6, pp 1381-1387, issn 0029-7844, 7 p.Article

Low-dose mifepristone for uterine leiomyomataEISINGER, Steven H; MELDRUM, Sean; FISCELLA, Kevin et al.Obstetrics and gynecology (New York. 1953). 2003, Vol 101, Num 2, pp 243-250, issn 0029-7844, 8 p.Article

Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristoneFISCELLA, Julietta; BONFIGLIO, Thomas; WINTERS, Paul et al.Human pathology. 2011, Vol 42, Num 7, pp 947-953, issn 0046-8177, 7 p.Article

Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion : A randomized trialSCHAFF, Eric A; FIELDING, Stephen L; WESTHOFF, Carolyn et al.JAMA, the journal of the American Medical Association. 2000, Vol 284, Num 15, pp 1948-1953, issn 0098-7484Article